Log In
BCIQ
Print this Print this
 

Testosterone undecanoate

  Manage Alerts
Collapse Summary General Information
Company SOV Therapeutics Inc.
DescriptionProdrug of testosterone
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationHypogonadism
Indication DetailsTreat constitutional delay in growth and puberty (CDGP) in adolescent boys; Treat hypogonadism
Regulatory Designation U.S. - Orphan Drug (Treat constitutional delay in growth and puberty (CDGP) in adolescent boys)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today